Bellevue Group’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Buy |
35,039
+27,075
| +340% | +$2.88M | 0.08% | 87 |
|
|
2025
Q1 | $725K | Sell |
7,964
-368
| -4% | -$33.5K | 0.02% | 113 |
|
|
2024
Q4 | $949K | Sell |
8,332
-389
| -4% | -$44.3K | 0.02% | 118 |
|
|
2024
Q3 | $1.04M | Buy |
+8,721
| New | +$1.04M | 0.02% | 116 |
|
|
2023
Q2 | – | Sell |
-196,480
| Closed | -$24.5M | – | 158 |
|
|
2023
Q1 | $24.5M | Sell |
196,480
-24,600
| -11% | -$3.06M | 0.36% | 70 |
|
|
2022
Q4 | $33.2M | Buy |
221,080
+67,500
| +44% | +$10.1M | 0.44% | 65 |
|
|
2022
Q3 | $20.7M | Buy |
153,580
+2,380
| +2% | +$321K | 0.3% | 82 |
|
|
2022
Q2 | $22.5M | Buy |
151,200
+39,434
| +35% | +$5.88M | 0.32% | 81 |
|
|
2022
Q1 | $19.1M | Sell |
111,766
-1,700
| -1% | -$290K | 0.22% | 95 |
|
|
2021
Q4 | $29.3M | Buy |
113,466
+100,766
| +793% | +$26M | 0.3% | 89 |
|
|
2021
Q3 | $3.47M | Sell |
12,700
-9,900
| -44% | -$2.7M | 0.04% | 137 |
|
|
2021
Q2 | $5.06M | Sell |
22,600
-22,900
| -50% | -$5.13M | 0.05% | 132 |
|
|
2021
Q1 | $4.97M | Buy |
45,500
+27,500
| +153% | +$3M | 0.05% | 130 |
|
|
2020
Q4 | $1.47M | Sell |
18,000
-31,500
| -64% | -$2.57M | 0.02% | 150 |
|
|
2020
Q3 | $3.43M | Sell |
49,500
-500
| -1% | -$34.6K | 0.05% | 132 |
|
|
2020
Q2 | $3.34M | Buy |
+50,000
| New | +$3.34M | 0.05% | 127 |
|